These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Thrombocytopenia and Spontaneous Intracranial Hemorrhage After Olanzapine Therapy. Cruz MD; Danoff R J Am Osteopath Assoc; 2017 Jul; 117(7):473-475. PubMed ID: 28662560 [TBL] [Abstract][Full Text] [Related]
48. Severe cardiovascular side effects of olanzapine in an elderly patient: case report. Lee TW; Tsai SJ; Hwang JP Int J Psychiatry Med; 2003; 33(4):399-401. PubMed ID: 15152790 [TBL] [Abstract][Full Text] [Related]
49. Olanzapine-induced neutropenia in a patient with systemiclupus erythematosus: a role of FcγRIIIb polymorphism? Salviati M; Ortona E; Colasanti T; Francia A; Pontecorvo S; Delle Chiaie R Lupus; 2012 Jan; 21(1):97-9. PubMed ID: 21965280 [TBL] [Abstract][Full Text] [Related]
50. Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies. Ramaswamy K; Masand PS; Nasrallah HA Ann Clin Psychiatry; 2006; 18(3):183-94. PubMed ID: 16923657 [TBL] [Abstract][Full Text] [Related]
51. Intermittent neutropenia and leucopenia unrelated to clozapine in a 12-year-old girl with schizophrenia. Wilson M; Offenberger JB J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):136-8. PubMed ID: 23480326 [No Abstract] [Full Text] [Related]
53. Neutropenia induced by second generation antipsychotics: a prospective investigation. Rettenbacher MA; Hofer A; Kemmler G; Fleischhacker WW Pharmacopsychiatry; 2010 Mar; 43(2):41-4. PubMed ID: 20175050 [TBL] [Abstract][Full Text] [Related]
54. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575 [TBL] [Abstract][Full Text] [Related]
55. Severe liver enzyme elevations after three years of olanzapine treatment: a case report and review of olanzapine associated hepatotoxicity. Ozcanli T; Erdogan A; Ozdemir S; Onen B; Ozmen M; Doksat K; Sonsuz A Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1163-6. PubMed ID: 16632162 [TBL] [Abstract][Full Text] [Related]
57. Rapidly developing hyperglycemia during treatment with olanzapine. Kohen I; Gampel M; Reddy L; Manu P Ann Pharmacother; 2008 Apr; 42(4):588-91. PubMed ID: 18364401 [TBL] [Abstract][Full Text] [Related]
58. Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia. Kinon BJ; Liu-Seifert H; Adams DH; Citrome L J Clin Psychopharmacol; 2006 Dec; 26(6):632-7. PubMed ID: 17110821 [TBL] [Abstract][Full Text] [Related]
59. Atypical antipsychotics in the treatment of fibromyalgia: a case series with olanzapine. Rico-Villademoros F; Hidalgo J; Dominguez I; García-Leiva JM; Calandre EP Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):161-4. PubMed ID: 15610961 [TBL] [Abstract][Full Text] [Related]
60. Adolescent weight loss during treatment with olanzapine. Cohen JA; Perel JM J Child Adolesc Psychopharmacol; 2004; 14(4):617-20. PubMed ID: 15662155 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]